When you live with pulmonary hypertension (PH) and need emergency medical services (EMS), the last thing you should have to worry about is whether responders know how to care for you. But this condition and its treatments may require specialized care that EMS professionals don’t encounter regularly. Without…
Discussion
A Phase 3 clinical trial testing IKT-001, an experimental oral formulation of imatinib that Inhibikase Therapeutics is developing to treat pulmonary arterial hypertension (PAH), is now enrolling participants at dozens of sites worldwide. According to Inhibikase, the IMPROVE-PAH trial (NCT07365332) is now active at 79 sites around…
Discussion
A Phase 2 clinical trial testing APL-9796, an experimental treatment for pulmonary hypertension, is currently recruiting participants. The trial, called ViTAL-PH (NCT06846554), is recruiting adults ages 18 to 80 with Group 1 pulmonary arterial hypertension (PAH). Participants must have a diagnosis confirmed by right heart catheterization…
Discussion
The American Lung Association has launched a national campaign to raise awareness of pulmonary arterial hypertension (PAH) and support families living with the rare lung disease that often takes a long time to diagnose. Announced during Pulmonary Hypertension Awareness Month, the campaign shares patient stories and introduces…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
